Literature DB >> 24905474

The protein tyrosine phosphatase PTPN22 controls forkhead box protein 3 T regulatory cell induction but is dispensable for T helper type 1 cell polarization.

G Fousteri1, T Jofra, I Debernardis, S M Stanford, A Laurenzi, N Bottini, M Battaglia.   

Abstract

Protein tyrosine phosphatases (PTPs) regulate T cell receptor (TCR) signalling and thus have a role in T cell differentiation. Here we tested whether the autoimmune predisposing gene PTPN22 encoding for a PTP that inhibits TCR signalling affects the generation of forkhead box protein 3 (FoxP3)(+) T regulatory (Treg ) cells and T helper type 1 (Th1) cells. Murine CD4(+) T cells isolated from Ptpn22 knock-out (Ptpn22(KO) ) mice cultured in Treg cell polarizing conditions showed increased sensitivity to TCR activation compared to wild-type (WT) cells, and subsequently reduced FoxP3 expression at optimal-to-high levels of activation. However, at lower levels of TCR activation, Ptpn22(KO) CD4(+) T cells showed enhanced expression of FoxP3. Similar experiments in humans revealed that at optimal levels of TCR activation PTPN22 knock-down by specific oligonucleotides compromises the differentiation of naive CD4(+) T cells into Treg cells. Notably, in vivo Treg cell conversion experiments in mice showed delayed kinetic but overall increased frequency and number of Treg cells in the absence of Ptpn22. In contrast, the in vitro and in vivo generation of Th1 cells was comparable between WT and Ptpn22(KO) mice, thus suggesting PTPN22 as a FoxP3-specific regulating factor. Together, these results propose PTPN22 as a key factor in setting the proper threshold for FoxP3(+) Treg cell differentiation.
© 2014 British Society for Immunology.

Entities:  

Keywords:  FoxP3+ Treg cells; PTPN22; Th1 cells

Mesh:

Substances:

Year:  2014        PMID: 24905474      PMCID: PMC4360206          DOI: 10.1111/cei.12393

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  53 in total

Review 1.  Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?

Authors:  Garth L Burn; Lena Svensson; Cristina Sanchez-Blanco; Manoj Saini; Andrew P Cope
Journal:  FEBS Lett       Date:  2011-04-20       Impact factor: 4.124

2.  Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo.

Authors:  Melanie Wiesel; Josh Crouse; Gregor Bedenikovic; Andrew Sutherland; Nicole Joller; Annette Oxenius
Journal:  Eur J Immunol       Date:  2011-12-20       Impact factor: 5.532

3.  TCR affinity and specificity requirements for human regulatory T-cell function.

Authors:  Gabriela Plesa; Lingjie Zheng; Andrew Medvec; Caleph B Wilson; Camila Robles-Oteiza; Nathaniel Liddy; Alan D Bennett; Jessie Gavarret; Annelise Vuidepot; Yangbing Zhao; Bruce R Blazar; Bent K Jakobsen; James L Riley
Journal:  Blood       Date:  2012-02-07       Impact factor: 22.113

4.  PTPN22 modulates macrophage polarization and susceptibility to dextran sulfate sodium-induced colitis.

Authors:  Hui-Hsin Chang; Shi-Chuen Miaw; William Tseng; Yi-Wei Sun; Chih-Chun Liu; Hsiao-Wei Tsao; I-Cheng Ho
Journal:  J Immunol       Date:  2013-08-02       Impact factor: 5.422

5.  Low-dose antigen promotes induction of FOXP3 in human CD4+ T cells.

Authors:  S Alice Long; Mary Rieck; Megan Tatum; Paul L Bollyky; Rebecca P Wu; Isabelle Muller; Jhon-Chun Ho; Heather G Shilling; Jane H Buckner
Journal:  J Immunol       Date:  2011-08-24       Impact factor: 5.422

Review 6.  Induced CD4+Foxp3+ regulatory T cells in immune tolerance.

Authors:  Angelina M Bilate; Juan J Lafaille
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

7.  A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models.

Authors:  Xuezhi Dai; Richard G James; Tania Habib; Swati Singh; Shaun Jackson; Socheath Khim; Randall T Moon; Denny Liggitt; Alejandro Wolf-Yadlin; Jane H Buckner; David J Rawlings
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

8.  The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses.

Authors:  Torkel Vang; Johannes Landskron; Marte K Viken; Nikolaus Oberprieler; Knut M Torgersen; Tomas Mustelin; Kjetil Tasken; Lutz Tautz; Robert C Rickert; Benedicte A Lie
Journal:  Hum Immunol       Date:  2013-01-17       Impact factor: 2.850

Review 9.  Roles of the protein tyrosine phosphatase PTPN22 in immunity and autoimmunity.

Authors:  Georgia Fousteri; Stamatis-Nick C Liossis; Manuela Battaglia
Journal:  Clin Immunol       Date:  2013-10-21       Impact factor: 3.969

10.  Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes.

Authors:  Alessandra Ferraro; Carlo Socci; Angela Stabilini; Andrea Valle; Paolo Monti; Lorenzo Piemonti; Rita Nano; Sven Olek; Paola Maffi; Marina Scavini; Antonio Secchi; Carlo Staudacher; Ezio Bonifacio; Manuela Battaglia
Journal:  Diabetes       Date:  2011-09-06       Impact factor: 9.461

View more
  14 in total

Review 1.  Anti-neutrophil Cytoplasmic Antibodies (ANCA) as Disease Activity Biomarkers in a "Personalized Medicine Approach" in ANCA-Associated Vasculitis.

Authors:  Mohammed S Osman; Jan Willem Cohen Tervaert
Journal:  Curr Rheumatol Rep       Date:  2019-12-26       Impact factor: 4.592

Review 2.  Regulation of autoimmune and anti-tumour T-cell responses by PTPN22.

Authors:  Rebecca J Brownlie; Rose Zamoyska; Robert J Salmond
Journal:  Immunology       Date:  2018-04-16       Impact factor: 7.397

3.  Lack of the protein tyrosine phosphatase PTPN22 strengthens transplant tolerance to pancreatic islets in mice.

Authors:  Georgia Fousteri; Tatiana Jofra; Roberta Di Fonte; Nicola Gagliani; Cristina Morsiani; Angela Stabilini; Manuela Battaglia
Journal:  Diabetologia       Date:  2015-03-07       Impact factor: 10.122

4.  Experimental colitis in IL-10-deficient mice ameliorates in the absence of PTPN22.

Authors:  T Jofra; G Galvani; I Cosorich; L De Giorgi; A Annoni; A Vecchione; C Sorini; M Falcone; G Fousteri
Journal:  Clin Exp Immunol       Date:  2019-07-10       Impact factor: 4.330

5.  Protein tyrosine phosphatase PTPN22 has dual roles in promoting pathogen versus homeostatic-driven CD8 T-cell responses.

Authors:  Tatiana Jofra; Roberta Di Fonte; Tarun Edgar Hutchinson; Farhad Dastmalchi; Giuseppe Galvani; Manuela Battaglia; Shahram Salek-Ardakani; Georgia Fousteri
Journal:  Immunol Cell Biol       Date:  2016-10-11       Impact factor: 5.126

6.  Redox regulation of PTPN22 affects the severity of T-cell-dependent autoimmune inflammation.

Authors:  Jaime James; Yifei Chen; Clara M Hernandez; Florian Forster; Markus Dagnell; Qing Cheng; Amir A Saei; Hassan Gharibi; Gonzalo Fernandez Lahore; Annika Åstrand; Rajneesh Malhotra; Bernard Malissen; Roman A Zubarev; Elias S J Arnér; Rikard Holmdahl
Journal:  Elife       Date:  2022-05-19       Impact factor: 8.713

Review 7.  Genetics of immune-mediated inflammatory diseases.

Authors:  T David; S F Ling; A Barton
Journal:  Clin Exp Immunol       Date:  2018-02-02       Impact factor: 4.330

Review 8.  PTPN22 and islet-specific autoimmunity: What have the mouse models taught us?

Authors:  Giuseppe Galvani; Georgia Fousteri
Journal:  World J Diabetes       Date:  2017-07-15

Review 9.  Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn's disease.

Authors:  Friederike Cordes; Dirk Foell; John Nik Ding; Georg Varga; Dominik Bettenworth
Journal:  World J Gastroenterol       Date:  2020-07-28       Impact factor: 5.742

10.  Overexpression of the PTPN22 Autoimmune Risk Variant LYP-620W Fails to Restrain Human CD4+ T Cell Activation.

Authors:  Daniel J Perry; Leeana D Peters; Priya Saikumar Lakshmi; Lin Zhang; Zhao Han; Clive H Wasserfall; Clayton E Mathews; Mark A Atkinson; Todd M Brusko
Journal:  J Immunol       Date:  2021-07-23       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.